In one study of human intestinal cells, Akkermansia alone was shown to increase natural GLP-1 levels by over 2,000%
While such a loss of weight may reduce risk factors for cardiovascular disease, the trial suggests that something more is going on
Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis
It was first FDA-approved in 2022, also as a treatment for controlling blood sugar in people with type 2 diabetes
Patients dealing with chronic joint pain, post-surgical discomfort, or inflammatory conditions often notice reduced pain within the first 12 weeks of a protocol
We understand that even minute impurities can compromise an entire study, leading to skewed data and wasted resources